360 related articles for article (PubMed ID: 14523084)
21. Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors.
Egan CT; Herrick-Davis K; Miller K; Glennon RA; Teitler M
Psychopharmacology (Berl); 1998 Apr; 136(4):409-14. PubMed ID: 9600588
[TBL] [Abstract][Full Text] [Related]
22. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.
Burris KD; Breeding M; Sanders-Bush E
J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849
[TBL] [Abstract][Full Text] [Related]
23. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
[TBL] [Abstract][Full Text] [Related]
24. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
[TBL] [Abstract][Full Text] [Related]
25. 5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat.
Marona-Lewicka D; Nichols DE
Neuropharmacology; 1997 Oct; 36(10):1471-5. PubMed ID: 9423936
[TBL] [Abstract][Full Text] [Related]
26. Hallucinogens and Serotonin 5-HT
López-Giménez JF; González-Maeso J
Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
[TBL] [Abstract][Full Text] [Related]
27. Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice.
Moreno JL; Holloway T; Umali A; Rayannavar V; Sealfon SC; González-Maeso J
Psychopharmacology (Berl); 2013 Jan; 225(1):217-26. PubMed ID: 22842765
[TBL] [Abstract][Full Text] [Related]
28. The selective 5-HT
Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
[TBL] [Abstract][Full Text] [Related]
29. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration.
Nichols CD; Garcia EE; Sanders-Bush E
Brain Res Mol Brain Res; 2003 Mar; 111(1-2):182-8. PubMed ID: 12654518
[TBL] [Abstract][Full Text] [Related]
30. Pimavanserin exhibits serotonin 5-HT
Muneta-Arrate I; Diez-Alarcia R; Horrillo I; Meana JJ
Eur Neuropsychopharmacol; 2020 Jul; 36():83-89. PubMed ID: 32517960
[TBL] [Abstract][Full Text] [Related]
31. Increased behavioral and neuronal responses to a hallucinogenic drug in PACAP heterozygous mutant mice.
Hazama K; Hayata-Takano A; Uetsuki K; Kasai A; Encho N; Shintani N; Nagayasu K; Hashimoto R; Reglodi D; Miyakawa T; Nakazawa T; Baba A; Hashimoto H
PLoS One; 2014; 9(2):e89153. PubMed ID: 24586556
[TBL] [Abstract][Full Text] [Related]
32. The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats.
Scruggs JL; Schmidt D; Deutch AY
Neurosci Lett; 2003 Aug; 346(3):137-40. PubMed ID: 12853103
[TBL] [Abstract][Full Text] [Related]
33. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
Gresch PJ; Strickland LV; Sanders-Bush E
Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572
[TBL] [Abstract][Full Text] [Related]
34. Selective and divergent regulation of cortical 5-HT(2A) receptors in rabbit.
Aloyo VJ; Dave KD; Rahman T; Harvey JA
J Pharmacol Exp Ther; 2001 Dec; 299(3):1066-72. PubMed ID: 11714896
[TBL] [Abstract][Full Text] [Related]
35. Serotonin 5-HT
García-Bea A; Miranda-Azpiazu P; Muguruza C; Marmolejo-Martinez-Artesero S; Diez-Alarcia R; Gabilondo AM; Callado LF; Morentin B; González-Maeso J; Meana JJ
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1453-1463. PubMed ID: 31734018
[TBL] [Abstract][Full Text] [Related]
36. Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice.
Qu Y; Chang L; Ma L; Wan X; Hashimoto K
Pharmacol Biochem Behav; 2023 Jan; 222():173500. PubMed ID: 36476377
[TBL] [Abstract][Full Text] [Related]
37. Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation.
Chang CW; Poteet E; Schetz JA; Gümüş ZH; Weinstein H
Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):213-25. PubMed ID: 18762202
[TBL] [Abstract][Full Text] [Related]
38. Serotonin 2A Receptor (5-HT
Duan W; Cao D; Wang S; Cheng J
Chem Rev; 2024 Jan; 124(1):124-163. PubMed ID: 38033123
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.
Halberstadt AL; Geyer MA
Psychopharmacology (Berl); 2013 Jun; 227(4):727-39. PubMed ID: 23407781
[TBL] [Abstract][Full Text] [Related]
40. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
